


Healthcare News Roundup: Biopharmaceutical
HSMN NewsFeed - 20 Feb 2018
Peritech Pharma's Novel Hemorrhoids Treatment Commercialized in 24 Countries
Peritech Pharma's Novel Hemorrhoids Treatment Commercialized in 24 Countries
HSMN NewsFeed - 15 Feb 2018
GT Biopharma Announces Appointment of Shawn M Cross as Chairman and Chief Executive Officer
GT Biopharma Announces Appointment of Shawn M Cross as Chairman and Chief Executive Officer
HSMN NewsFeed - 14 Feb 2018
Teligent, Inc. Announces FDA Approval of Betamethasone Dipropionate Lotion USP (Augmented), 0.05%
Teligent, Inc. Announces FDA Approval of Betamethasone Dipropionate Lotion USP (Augmented), 0.05%
HSMN NewsFeed - 14 Feb 2018
SanBio and Teijin to Terminate Licensing Agreement regarding SB623 for Stroke Treatment
SanBio and Teijin to Terminate Licensing Agreement regarding SB623 for Stroke Treatment
HSMN NewsFeed - 13 Feb 2018
Aptinyx Appoints Ashish Khanna Chief Financial Officer and Chief Business Officer
Aptinyx Appoints Ashish Khanna Chief Financial Officer and Chief Business Officer
HSMN NewsFeed - 12 Feb 2018
Regeneron Announces Appointment of Marion McCourt as Senior Vice President and Head of Commercial
Regeneron Announces Appointment of Marion McCourt as Senior Vice President and Head of Commercial
HSMN NewsFeed - 8 Feb 2018
SIGA Technologies Announces FDA Accepts NDA and Grants Priority Review for Oral TPOXX to Treat Smallpox
SIGA Technologies Announces FDA Accepts NDA and Grants Priority Review for Oral TPOXX to Treat Smallpox
HSMN NewsFeed - 8 Feb 2018
Novo Nordisk Launches Rebinyn(R) in the United States for People with Hemophilia B
Novo Nordisk Launches Rebinyn(R) in the United States for People with Hemophilia B
HSMN NewsFeed - 7 Feb 2018
UNITY Biotechnology Adds Accomplished R&D Leader David L. Lacey, M.D., to Board of Directors
UNITY Biotechnology Adds Accomplished R&D Leader David L. Lacey, M.D., to Board of Directors
HSMN NewsFeed - 5 Feb 2018
FDA Clears Oricula Therapeutics Investigational New Drug Application for Clinical Trials
FDA Clears Oricula Therapeutics Investigational New Drug Application for Clinical Trials
HSMN NewsFeed - 5 Feb 2018
Trethera Corporation Announces FDA Clearance of Investigational New Drug Application for TRE-515
Trethera Corporation Announces FDA Clearance of Investigational New Drug Application for TRE-515
HSMN NewsFeed - 1 Feb 2018
Mylan Expands Access to HIV/AIDS Medicines with Launch of First Generic Sustiva(R) Tablets
Mylan Expands Access to HIV/AIDS Medicines with Launch of First Generic Sustiva(R) Tablets
HSMN NewsFeed - 31 Jan 2018
Intec Pharma Names R. Michael Gendreau, M.D., Ph.D. as Chief Medical Officer
Intec Pharma Names R. Michael Gendreau, M.D., Ph.D. as Chief Medical Officer
HSMN NewsFeed - 30 Jan 2018
FDA Grants Orphan Drug Designation to Dauntless Pharmaceuticals' DP1038 for the Treatment of Acromegaly
FDA Grants Orphan Drug Designation to Dauntless Pharmaceuticals' DP1038 for the Treatment of Acromegaly
HSMN NewsFeed - 24 Jan 2018
Perrigo Announces Final FDA Approval Of A Generic Version Of Estrace(R) Cream
Perrigo Announces Final FDA Approval Of A Generic Version Of Estrace(R) Cream
HSMN NewsFeed - 24 Jan 2018
Perrigo Announces Final FDA Approval And Launch Of An AB Rated Generic Version Of Epiduo(R) Gel
Perrigo Announces Final FDA Approval And Launch Of An AB Rated Generic Version Of Epiduo(R) Gel
HSMN NewsFeed - 24 Jan 2018
Advicenne Appoints Linda Law, MD as US Vice President, Clinical Development and Medical Affairs
Advicenne Appoints Linda Law, MD as US Vice President, Clinical Development and Medical Affairs
HSMN NewsFeed - 22 Jan 2018
Symic Bio Appoints Hicham Alaoui, Ph.D., as Senior Vice President of Discovery Biology
Symic Bio Appoints Hicham Alaoui, Ph.D., as Senior Vice President of Discovery Biology
HSMN NewsFeed - 22 Jan 2018
Regeneron Announces Approval of DUPIXENT(R) (dupilumab) in Japan for the Treatment of Atopic Dermatitis
Regeneron Announces Approval of DUPIXENT(R) (dupilumab) in Japan for the Treatment of Atopic Dermatitis
HSMN NewsFeed - 22 Jan 2018
Titan In Discussions With Braeburn Regarding U.S. Probuphine(R) Commercialization
Titan In Discussions With Braeburn Regarding U.S. Probuphine(R) Commercialization
HSMN NewsFeed - 17 Jan 2018
Avion Pharmaceuticals announces approval of first NDA in the oral contraceptive category
Avion Pharmaceuticals announces approval of first NDA in the oral contraceptive category
HSMN NewsFeed - 16 Jan 2018
RXi Pharmaceuticals Announces Business Strategy to Focus on Immuno-Oncology Programs to Accelerate Growth
RXi Pharmaceuticals Announces Business Strategy to Focus on Immuno-Oncology Programs to Accelerate Growth
HSMN NewsFeed - 11 Jan 2018
Resverlogix Receives FDA Protocol Acceptance for the Ongoing Phase 3 BETonMACE Trial
Resverlogix Receives FDA Protocol Acceptance for the Ongoing Phase 3 BETonMACE Trial
HSMN NewsFeed - 10 Jan 2018
BYDUREON(R) BCise(TM) Injectable Medicine Now Available In The US For Patients With Type-2 Diabetes
BYDUREON(R) BCise(TM) Injectable Medicine Now Available In The US For Patients With Type-2 Diabetes
HSMN NewsFeed - 9 Jan 2018
Syapse Enters Strategic Collaboration with Roche to Advance Precision Medicine in Oncology
Syapse Enters Strategic Collaboration with Roche to Advance Precision Medicine in Oncology
HSMN NewsFeed - 8 Jan 2018
STORM Therapeutics Extends Series A Round to Include New Investor Taiho Ventures
STORM Therapeutics Extends Series A Round to Include New Investor Taiho Ventures
HSMN NewsFeed - 5 Jan 2018
Pernix Announces Reorganization of Sales Force to Focus on Zohydro(R) ER with BeadTek(TM) and Silenor(R)
Pernix Announces Reorganization of Sales Force to Focus on Zohydro(R) ER with BeadTek(TM) and Silenor(R)
HSMN NewsFeed - 4 Jan 2018
Neurogastrx, Inc. Raises $45M Series A To Bring Lead GI Candidate Through Proof Of Concept
Neurogastrx, Inc. Raises $45M Series A To Bring Lead GI Candidate Through Proof Of Concept
HSMN NewsFeed - 3 Jan 2018
Agenus Announces Key Leadership to Advance Combination Trials For Planned BLA Filings
Agenus Announces Key Leadership to Advance Combination Trials For Planned BLA Filings
HSMN NewsFeed - 3 Jan 2018
Denovo Biopharma Opens New R&D Center, Names Chief Medical Officer and Chief Financial Officer
Denovo Biopharma Opens New R&D Center, Names Chief Medical Officer and Chief Financial Officer
HSMN NewsFeed - 29 Dec 2017
Mylan Adds to U.S. Women's Healthcare Portfolio With FDA Approval of First Generic for Estrace(R) Cream
Mylan Adds to U.S. Women's Healthcare Portfolio With FDA Approval of First Generic for Estrace(R) Cream
HSMN NewsFeed - 27 Dec 2017
Protalix BioTherapeutics’ PRX-102 Granted Orphan Drug Designation by the European Commission
Protalix BioTherapeutics’ PRX-102 Granted Orphan Drug Designation by the European Commission
HSMN NewsFeed - 27 Dec 2017
Eloxx Pharmaceuticals Appoints Robert Ward Chairman and Chief Executive Officer
Eloxx Pharmaceuticals Appoints Robert Ward Chairman and Chief Executive Officer
